Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Six-minute stepper test for people with peripheral artery disease

Official title: Examination of the Validity and Reliability of 6-minute Stepper Test in Patients With Peripheral Artery Disease

Run by Gazi University · NCT07169045 · Data updated 2026-11-12

This project will test whether the six-minute stepper test can measure exercise ability in adults with peripheral artery disease.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment24 (estimated)
SponsorGazi University
Academic / other
Locations1 site (Ankara, Çankaya)
StatusRecruiting
StartedSeptember 24, 2025
Main results expectedJuly 24, 2026
Study endsJuly 24, 2026
Registry record updatedFebruary 3, 2026
Trial IDNCT07169045 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are stable adults (18–80 years) with diagnosed peripheral artery disease (ABI criteria or calcified vessels), weighing ≤110 kg, who can safely perform stepper exercise and who volunteer to participate.

Probably not a fit

Patients with recent major cardiac events or surgery, unstable coronary disease, uncontrolled diabetes, pulmonary disease, active infection, prior ischemic amputation, pregnancy/breastfeeding, or those unable to step safely (including weight >110 kg) are unlikely to benefit from this test or be eligible for participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will recruit adults aged 18–80 with diagnosed peripheral artery disease at Gazi University's Cardiopulmonary Rehabilitation Unit. Participants will perform the six-minute stepper test (6MST), likely with repeat testing for reliability, alongside reference measures of exercise capacity and related variables such as muscle oxygenation, balance, intermittent claudication pain, lower extremity strength, and arterial stiffness. The study will compare 6MST results with established measures (such as cardiopulmonary exercise testing or other functional tests) to examine agreement and correlations. Data analysis will focus on validity (how well the 6MST reflects true exercise capacity) and test-retest reliability in this patient group.

Why it matters

Potential benefit: If successful, the 6MST could offer a simple, low-cost way to measure exercise capacity and help guide exercise programs for patients with PAD.

How similar studies have gone: The 6MST has shown validity and reliability in various pulmonary and cardiovascular populations, but its use specifically in PAD patients is largely untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed with peripheral artery disease by the Department of Cardiovascular Surgery,
* Ankle-brachial index (ABI) ≤1.40 or exercise ABI ≤0.73 or diagnosed with calcified vascular response, in remission and under follow-up,
* Stable,
* Ages between 18 and 80,
* Patients who volunteer to participate in the study will be included.

Exclusion Criteria:

* Patients will be excluded if they have:
* Previously underwent ischaemic amputation,
* Unstable coronary artery disease,
* Uncontrolled Diabetes Mellitus,
* Pulmonary disease,
* Acute infection,
* Weight \>110 kg because it is the upper limit of the stepper device,
* Contraindications to exercise testing per the American Sports Medicine Association,
* Pregnant and breastfeeding women,
* Patients with PAD who have undergone major surgery or had a myocardial infarction within the last 3 months.

Where it's running

  • Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit
    Ankara, Çankaya, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.